DAIC

JUNE 12, 2024

and an investigator in the VIVID study , which contributed to the device’s FDA approval – successfully used the Duo Venous Stent System for the first time outside of a clinical trial. Duo Hybrid has a distinct integrated design that combines multiple zones of differing mechanical properties into a single stent [3].

Stents 105

Stents Stent Anatomy Ultrasound 105

DAIC

MARCH 20, 2024

The newly CE launched Freesolve RMS for coronary artery lesions, based on the BIOmag magnesium alloy and the proven Orsiro drug-eluting stent (DES) coating technology, provides safety, improved deliverability, and optimal performance and vessel support during and after implantation.2,3 2,3 It has shown 99.6%

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Technology Coronary Artery Disease 105

DAIC

JUNE 18, 2024

1 To date, interventional treatment of coronary artery disease with drug-eluting stents has been able to establish flow angiographically. 2 “For many years, it was thought that caging of the vessel with stents was the main driver for annual increasing non-plateauing event rates. of the U.S. population. JACC 2020. 5 Saito S, et al.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

DAIC

MARCH 28, 2025

vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible. This innovative technology maximizes operational efficiency, enhances staff expertise, and delivers better patient outcomes, making it a wise long-term investment. 2012) 380:2095128. link] iv IMV.2023

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59